On April 19, 2017, after a two-week trial, a federal jury unanimously acquitted Revolutions Medical Corporation (RMCP) CEO Rondald Wheet on all three counts of securities fraud and false filings with the Securities and Exchange Commission (SEC).
On February 9, 2016, the federal grand jury returned an indictment against
Bart Daniel, former United States Attorney
RMCP is a small South Carolina-based company that develops and distributes innovative products and tools for the medical industry. The company largely focuses on creating and perfecting an auto-retractable vacuum safety syringe. Their primary product— the FDA-cleared RevVac™ Auto-Retractable Vacuum Safety Syringe—was designed to substantially reduce accidental needle stick injuries, using patented vacuum technology to retract the needle directly into the plunger after use, thus preventing its reuse once its safety feature had been activated. RMCP’s RevVac syringe included five international patents and two U.S. patents in order to protect the product and RMCP.
The government contended that
Defense attorneys Daniel and Sullivan culled through a decade’s worth of company history, reports, filings, contracts, financial documents, and employee backgrounds to prepare for and combat the issues presented by the government.
Daniel focused on each of the consultants and highlighted their individual strengths,
Sullivan cross-examined the co-defendant and led
Both attorneys carefully cross-examined the government’s witnesses. Among those were FBI investigating agents, forensic accountants, and securities analysts as well as past employees of the medical device company, including the co-defendant.
At the close of the trial, the federal jury returned a unanimous not guilty verdict
Bart Daniel defends government investigations in the areas of health care, securities, antitrust, and the False Claims Act, among others. Daniel has defended corporate officers and board members as well as